By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sunshine Biopharma, Inc. 

6100 Royalmount Avenue

Montreal  Quebec  H4P 2R2  Canada
Phone: 514-496-5197 Fax: 450-689-639



Company News
Sunshine Biopharma, Inc. Signs Licensing Agreement For Anastrozole, The Company's First Generic Drug For Treatment Of Breast Cancer 5/12/2016 12:12:48 PM
Sunshine Biopharma, Inc. Eliminates The Debt Obligations Associated With The Recently Acquired Patents For Its Adva-27a Anticancer Compound 3/16/2016 10:12:00 AM
Sunshine Biopharma, Inc. Is Moving Forward With Its Development Plans For Adva-27a Anticancer Compound 1/20/2016 12:01:28 PM
Sunshine Biopharma, Inc. Acquires All Remaining Worldwide Patents For Its Adva-27a Anticancer Compound 12/28/2015 12:45:33 PM
Sunshine Biopharma, Inc. Acquires The U.S. Patent For Its Anticancer Compound, Adva-27a 10/13/2015 1:18:47 PM
Sunshine Biopharma, Inc. Announces That The Initial Manufacturing Sample Of Its Anticancer Compound Adva-27a Meets Biological Specifications Paving The Way For Clinical Trials 8/4/2015 11:29:12 AM
Sunshine Biopharma, Inc. To Receive This Week A Sample From The Adva-27a Manufacturing Currently Underway At Lonza Inc. In Switzerland 5/27/2015 11:22:45 AM
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In India 3/24/2015 8:36:54 AM
Sunshine Biopharma, Inc. Announces Change To Its Board Of Directors And Officers 2/26/2015 10:25:06 AM
Sunshine Biopharma, Inc. Signs Agreement With Lonza Biologics Inc. (LONN.VX) To Manufacture Its Lead Anti-Cancer Compound, Adva-27a 11/20/2014 8:42:07 AM